Non-Operative Management of Rectal Cancer with Adjuvant Chemotherapy after Chemoradiotherapy (NORMANDY): Prospective Study
NOM with adjuvant capecitabine showed promising oncological outcomes, offering an alternative to passive watch-and-wait approaches. Further refinement through multidisciplinary strategies is warranted.
Authors
- Jason Joon Bock Lee
- Heon‐Ju Kwon (ORCID: https://orcid.org/0000-0002-8157-6575)
- Yoon Suk Jung (ORCID: https://orcid.org/0000-0002-1963-7170)
- Soo‐Kyung Park (ORCID: https://orcid.org/0000-0001-8822-9632)
- Kyung Uk Jung (ORCID: https://orcid.org/0000-0002-8844-3724)
- Dong Il Park (ORCID: https://orcid.org/0000-0003-2307-8575)
- Mi Sung Kim (ORCID: https://orcid.org/0000-0002-1523-1544)
- Hyung Ook Kim (ORCID: https://orcid.org/0000-0003-0603-8766)
- Dong‐Hoe Koo (ORCID: https://orcid.org/0000-0001-9913-8883)
- Hungdai Kim
- Hyo‐Joon Yang (ORCID: https://orcid.org/0000-0002-0265-672X)
- Jung Ho Park (ORCID: https://orcid.org/0000-0003-2568-128X)
- Eo Jin Kim (ORCID: https://orcid.org/0000-0001-9475-6930)
- Hyebin Lee (ORCID: https://orcid.org/0000-0001-8442-6479)
- Ho-Kyung Chun (ORCID: https://orcid.org/0000-0003-0142-9063)
- In-Gu Do
Institutions
- Kangbuk Samsung Hospital (KR)
- Jeju National University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-05-15
- DOI
- https://doi.org/10.4143/crt.2025.148
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Samsung